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Autologous deep vein reconstruction of infected
thoracoabdominal aortic patch graft
Andrew L. Tambyraja, MRCSEd, Michael G. Wyatt, MSc, FRCS, Michael J. Clarke, MD, FRCSEd, and
Roderick T. A. Chalmers, MD, FRCSEd, Edinburgh, Scotland
Graft infection remains a serious complication of prosthetic aortic repair. Infection of thoracoabdominal aortic prosthetic
grafts, in particular, is a significant clinical challenge and is associated with high mortality. We report successful in situ
reconstruction of an infected thoracoabdominal aortic prosthetic patch graft with autogenous superficial femoral vein. To
our knowledge, this is the first such case described in the North American and English language surgical literature. At
24-month follow-up the patient remains well, with no evidence of sepsis or graft complication at clinical and radiologic
assessment. (J Vasc Surg 2003;38:852-4.)
Graft infection is a serious complication of prosthetic
aortic repair. Mortality rates after thoracic aortic graft sepsis
may be as high as 75%.1 The established principles of
surgical treatment in prosthetic aortic graft infection entail
eradication of sepsis with removal of infected graft followed
by revascularization. However, in the management of tho-
racoabdominal graft infection, blood flow to the visceral
and spinal vessels and to the lower extremities must be
maintained, thus mandating in situ reconstruction.
We report the successful replacement of an infected
thoracoabdominal prosthetic aortic patch graft with in situ
autologous superficial femoral vein.
CASE REPORT
A previously fit 23-year-old white man was referred to our
vascular surgical service with mid-aortic syndrome, identified dur-
ing investigation for hypertension. Aortograms demonstrated ste-
nosis of the visceral aorta commencing at the level of the celiac axis
and extending to just below the renal arteries. A decision was made
to proceed with patch angioplasty of the lesion.
Through a left thoracolaparotomy, transperitoneal medial vis-
ceral rotation was performed, enabling access to the visceral aorta.
Stenosis extending from the origin of the celiac artery to the renal
arteries was confirmed. After mobilizing the vessels and adminis-
tering 5000 units of intravenous heparin, supraceliac and infrarenal
aortic clamps were applied. The area of aortic stenosis was opened,
and visceral artery backbleeding was controlled with balloon oc-
clusion catheters. Patch angioplasty was undertaken with a knitted
Dacron graft (Sulzer Vascutek, Inchinnan, Scotland) and 3/0
polypropylene sutures. The viscera and lower limbs were reper-
fused sequentially. Postoperatively the patient was transferred to
the intensive care unit for 24 hours. Recovery was unremarkable,
and the patient was discharged to home 10 days after surgery.
Three months later the patient returned with systemic malaise
and rigors. Clinical examination revealed fever, with a soft abdo-
men and well-healed wound. White blood cell count was normal,
although C-reactive protein was elevated at 126 mg/L. Blood
cultures revealed methicillin-sensitive Staphylococcus aureus bacte-
remia. Parenteral vancomycin and flucloxacillin therapy was
started. At contrast material–enhanced computed tomography
and aortography, a periaortic graft pseudoaneurysm was identified
adjacent to the proximal anastomosis (Figs 1, 2). Aortic graft
infection was diagnosed, and it was decided to perform radical graft
excision together with autologous vein reconstruction.
At operation, long saphenous vein was harvested from the
right leg and found to be of narrow caliber. Superficial femoral vein
was thus harvested from the left leg, from the level of the profunda
vein to the distal third of the thigh. Thereafter, repeat thoracolap-
arotomy with transperitoneal medial visceral rotation enabled ac-
cess to the visceral aorta. An inflammatory mass was identified at
the site of the previous aortic repair. After intravenous administra-
tion of 3000 units of heparin, supraceliac and infrarenal aortic
clamps were applied. The inflammatory mass was opened, enabling
entry into the pseudoaneurysm cavity, and frank pus was expressed.
The visceral and renal arteries were controlled with balloon occlu-
sion catheters. The existing Dacron patch and involved aortic wall
were excised, and the para-aortic tissues were widely debrided,
leaving an aortic defect 2  6 cm and incorporating 60% of the
aortic circumference. The infected field was irrigated with 1 g of
rifampicin. The superficial femoral vein graft was opened longitu-
dinally and sutured to the freshened edges of the aorta with 3/0
polypropylene sutures. Postoperatively the patient was transferred
to the intensive care unit for 24 hours. Microbiological examina-
tion of debrided tissue specimens revealed pus cells but no growth
on culture. Parenteral antibiotic therapy was continued for 2 weeks
after operation. Thereafter, oral flucloxacillin was administered.
Recovery was complicated by Escherichia coli urinary tract infec-
tion, which was treated with oral ciprofloxacin. The patient was
discharged from the hospital 11 days after the operation, with
continued oral flucloxacillin therapy.
At 24-month follow-up the patient remained clinically asymp-
tomatic, and has had no long-term lower limb complications.
Inflammatory markers have returned to normal, and repeat com-
puted tomography scans demonstrate an intact repair with no
evidence of graft complication (Fig 3).
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Svensson et al2 in their review of 1509 thoracoabdomi-
nal aortic operations reported an incidence of prosthetic
graft infection of about 1.7%. The gravity of such a com-
plication is illustrated by Crawford’s series of 13 patients
with infected thoracoabdominal graft infection, of whom
11 died as a consequence of graft sepsis.3
The traditional management of aortic graft infection
has entailed radical resection of the graft, together with
extra-anatomic bypass. Such an approach is associated with
high mortality, prolonged hospital stay, repeat operation,
and a significant rate of limb loss.4 Thoracoabdominal graft
infection generally demands in situ revascularization or
preservation of an existing infected graft to maintain vis-
ceral and spinal arterial inflow.5 However, in situ prosthetic
graft reconstruction within a previously infected field or
preservation of an infected graft is associated with consid-
erable risk for recurrent graft sepsis. To reduce this risk, use
of biological grafts for in situ reconstruction has been
advocated. Previous reports have documented successful
management of thoracoabdominal aortic graft infection
with arterial autografts and allografts.5,6 Only anecdotal
reports of the former approach exist, and demand sacrific-
ing a “donor” arterial segment, together with complex
reconstruction. Greater experience exists with use of cryo-
preserved aortic allografts for treatment of thoracic aortic
graft infection. Nonetheless, the risk for late graft rupture
and infection associated with this technique does not justify
its preferential use in prosthetic aortic graft sepsis.7
Autologous deep veins for arterial reconstruction have
been used successfully in infrarenal abdominal aortic pros-
thetic graft infection, with an associated mortality rate of
only 7% to 10%.8,9 However, use of such a technique in
management of thoracoabdominal aortic graft infection has
not previously been described. Superficial femoral vein
confers all the benefits of an autogenous biologic graft
while remaining easy to harvest and reconstruct as an
arterial conduit. Theoretical concerns regarding risk for late
graft infection and aneurysm change have been raised.
However, Clagett et al,9 in their review of 41 patients with
deep vein aortoiliac or femoral reconstructions, failed to
identify any such problems. Furthermore, Wells et al10
demonstrated minimal mid-term to late-term lower ex-
tremity venous morbidity despite outflow obstruction after
superficial femoropopliteal vein harvesting.
Fig 1. Preoperative computed tomography scan shows aortic
pseudoaneurysm (arrow).
Fig 2. Preoperative aortogram shows pseudoaneurysm at proxi-
mal graft anastomosis.
Fig 3. Computed tomography scan at 12 months demonstrates
normal caliber aorta.
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Our patient’s relative youth, and preservation of a
portion of the native thoarcoabdominal aorta no doubt
contributed to successful management. Nevertheless, tho-
racoabdominal aortic graft infection remains a complex
problem. Where feasible, graft excision and arterial recon-
struction should be the recommended treatment strategy.
Autologous deep vein is a useful arterial conduit for attain-
ment of these goals. Although regular radiologic surveil-
lance, together with antibiotic prophylaxis, is recom-
mended and long-term follow-up is lacking, early results
are cause for optimism.
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